{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T22:22:26Z","timestamp":1788733346541,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T00:00:00Z","timestamp":1662508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologie"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00117-022-01059-7","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T12:02:49Z","timestamp":1662552169000},"page":"1050-1057","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Neurofibromatose Typ\u00a01","Neurofibromatosis type\u00a01"],"prefix":"10.1007","volume":"62","author":[{"given":"Rebecca","family":"Anders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz Wolfgang","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,7]]},"reference":[{"key":"1059_CR1","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00256-019-03290-1","volume":"49","author":"S Ahlawat","year":"2020","unstructured":"Ahlawat\u00a0S, Blakeley\u00a0JO, Langmead\u00a0S et\u00a0al (2020) Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Skelet Radiol 49:199\u2013219. https:\/\/doi.org\/10.1007\/s00256-019-03290-1","journal-title":"Skelet Radiol"},{"key":"1059_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1148\/radiology.172.2.2501822","volume":"172","author":"S Aoki","year":"1989","unstructured":"Aoki\u00a0S, Barkovich\u00a0AJ, Nishimura\u00a0K et\u00a0al (1989) Neurofibromatosis types 1 and 2: cranial MR findings. Radiology 172:527\u2013534. https:\/\/doi.org\/10.1148\/radiology.172.2.2501822","journal-title":"Radiology"},{"key":"1059_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13023-020-1310-3","volume":"15","author":"C Bergqvist","year":"2020","unstructured":"Bergqvist\u00a0C, Servy\u00a0A, Valeyrie-Allanore\u00a0L et al (2020) Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966. Orphanet J Rare Dis 15:37. https:\/\/doi.org\/10.1186\/s13023-020-1310-3","journal-title":"Orphanet J Rare Dis"},{"key":"1059_CR4","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1097\/WNO.0000000000000550","volume":"37","author":"PMK de Blank","year":"2017","unstructured":"de Blank\u00a0PMK, Fisher\u00a0MJ, Liu\u00a0GT et\u00a0al (2017) Optic pathway gliomas in neurofibromatosis type 1: an update: surveillance, treatment indications, and biomarkers of vision. J\u00a0Neuroophthalmol 37:S23\u2013S32. https:\/\/doi.org\/10.1097\/WNO.0000000000000550","journal-title":"J Neuroophthalmol"},{"key":"1059_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/WNO.0000000000000550","volume":"37","author":"PMK de Blank","year":"2017","unstructured":"de Blank\u00a0PMK, Fisher\u00a0MJ, Liu\u00a0GT et\u00a0al (2017) Optic pathway gliomas in neurofibromatosis type 1: an update: surveillance, treatment indications, and biomarkers of vision. J\u00a0Neuroophthalmol 37:23\u2013S32. https:\/\/doi.org\/10.1097\/WNO.0000000000000550","journal-title":"J Neuroophthalmol"},{"key":"1059_CR6","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6740","author":"S Calvez","year":"2020","unstructured":"Calvez\u00a0S, Levy\u00a0R, Calvez\u00a0R et\u00a0al (2020) Focal areas of high signal intensity in children with neurofibromatosis type 1: expected evolution on MRI. AJNR Am J Neuroradiol. https:\/\/doi.org\/10.3174\/ajnr.A6740","journal-title":"AJNR Am J Neuroradiol"},{"key":"1059_CR7","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6740","author":"S Calvez","year":"2020","unstructured":"Calvez\u00a0S, Levy\u00a0R, Calvez\u00a0R et\u00a0al (2020) Focal areas of high signal intensity in children with neurofibromatosis type 1: expected evolution on MRI. AJNR Am J Neuroradiol. https:\/\/doi.org\/10.3174\/ajnr.A6740","journal-title":"AJNR Am J Neuroradiol"},{"key":"1059_CR8","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S0748-7983(03)00055-6","volume":"29","author":"S Cardona","year":"2003","unstructured":"Cardona\u00a0S, Schwarzbach\u00a0M, Hinz\u00a0U et al (2003) Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours. Eur J Surg Oncol 29:536\u2013541. https:\/\/doi.org\/10.1016\/S0748-7983(03)00055-6","journal-title":"Eur J Surg Oncol"},{"key":"1059_CR9","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/B978-0-444-64076-5.00051-X","volume":"148","author":"PJ Cimino","year":"2018","unstructured":"Cimino\u00a0PJ, Gutmann\u00a0DH (2018) Neurofibromatosis type 1. Handb Clin Neurol 148:799\u2013811","journal-title":"Handb Clin Neurol"},{"key":"1059_CR10","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1002\/ajmg.a.33045","volume":"149","author":"F Elefteriou","year":"2009","unstructured":"Elefteriou\u00a0F, Kolanczyk\u00a0M, Schindeler\u00a0A et\u00a0al (2009) Skeletal abnormalities in neurofibromatosis type 1: approaches to therapeutic options. Am J Med Genet\u00a0A 149:2327\u20132338. https:\/\/doi.org\/10.1002\/ajmg.a.33045","journal-title":"Am J Med Genet A"},{"issue":"8","key":"1059_CR11","first-page":"4095","volume":"36","author":"RE Friedrich","year":"2016","unstructured":"Friedrich\u00a0RE, Nuding\u00a0MA (2016) Optic pathway glioma and cerebral focal abnormal signal intensity in patients with neurofibromatosis type 1: characteristics, treatment choices and follow-up in 134 affected individuals and a brief review of the literature. Anticancer Res 36(8):4095\u20134121","journal-title":"Anticancer Res"},{"key":"1059_CR12","unstructured":"Gemeinsame Leitsymptome und Diagnostik der ZNS-Tumoren im Kindes-und Jugendalter."},{"key":"1059_CR13","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1542\/peds.104.4.e49","volume":"104","author":"PD Griffiths","year":"1999","unstructured":"Griffiths\u00a0PD, Blaser\u00a0S, Mukonoweshuro\u00a0W et\u00a0al (1999) Neurofibromatosis bright objects in children with neurofibromatosis type 1: a proliferative potential? Pediatrics 104:e49. https:\/\/doi.org\/10.1542\/peds.104.4.e49","journal-title":"Pediatrics"},{"key":"1059_CR14","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s00132-021-04130-8","volume":"50","author":"CE Heyde","year":"2021","unstructured":"Heyde\u00a0CE, V\u00f6lker\u00a0A, von der H\u00f6h\u00a0NH et\u00a0al (2021) Spinal deformity in neurofibromatosis type 1. Orthopade 50:650\u2013656. https:\/\/doi.org\/10.1007\/s00132-021-04130-8","journal-title":"Orthopade"},{"key":"1059_CR15","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/brain\/111.6.1355","volume":"111","author":"SM Huson","year":"1988","unstructured":"Huson\u00a0SM, Harper\u00a0PS, Compston\u00a0DAS (1988) Von Recklinghausen Neurofibromatosis. Brain 111:1355\u20131381. https:\/\/doi.org\/10.1093\/brain\/111.6.1355","journal-title":"Brain"},{"key":"1059_CR16","first-page":"1513","volume":"15","author":"T Itoh","year":"1994","unstructured":"Itoh\u00a0T, Magnaldi\u00a0S, White\u00a0RM et\u00a0al (1994) Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. AJNR Am J Neuroradiol 15:1513\u20131519","journal-title":"AJNR Am J Neuroradiol"},{"key":"1059_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1177\/0883073812448531","volume":"28","author":"B Kaas","year":"2013","unstructured":"Kaas\u00a0B, Huisman\u00a0TAGM, Tekes\u00a0A et\u00a0al (2013) Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1. J\u00a0Child Neurol 28:561\u2013569. https:\/\/doi.org\/10.1177\/0883073812448531","journal-title":"J Child Neurol"},{"key":"1059_CR18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1177\/0883073812448531","volume":"28","author":"B Kaas","year":"2013","unstructured":"Kaas\u00a0B, Huisman\u00a0TAGM, Tekes\u00a0A et\u00a0al (2013) Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1. J\u00a0Child Neurol 28:561\u2013569. https:\/\/doi.org\/10.1177\/0883073812448531","journal-title":"J Child Neurol"},{"key":"1059_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11020444","author":"A Kaspiris","year":"2022","unstructured":"Kaspiris\u00a0A, Savvidou\u00a0OD, Vasiliadis\u00a0ES et\u00a0al (2022) Current aspects on the pathophysiology of bone metabolic defects during progression of scoliosis in neurofibromatosis type 1. J\u00a0Clin Med. https:\/\/doi.org\/10.3390\/jcm11020444","journal-title":"J Clin Med"},{"key":"1059_CR20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<38::AID-AJMG8>3.0.CO;2-M","volume":"89","author":"R Listernick","year":"1999","unstructured":"Listernick\u00a0R, Charrow\u00a0J, Gutmann\u00a0DH (1999) Intracranial gliomas in neurofibromatosis type 1. Am J Med Genet 89:38\u201344. https:\/\/doi.org\/10.1002\/(SICI)1096-8628(19990326)89:1\u300838::AID-AJMG8\u30093.0.CO;2\u2011M","journal-title":"Am J Med Genet"},{"key":"1059_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ana.21107","volume":"61","author":"R Listernick","year":"2007","unstructured":"Listernick\u00a0R, Ferner\u00a0RE, Liu\u00a0GT, Gutmann\u00a0DH (2007) Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 61:189\u2013198. https:\/\/doi.org\/10.1002\/ana.21107","journal-title":"Ann Neurol"},{"key":"1059_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00247-007-0712-x","volume":"38","author":"JR Lopes Ferraz Filho","year":"2008","unstructured":"Lopes Ferraz Filho\u00a0JR, Munis\u00a0MP, Soares Souza\u00a0A et\u00a0al (2008) Unidentified bright objects on brain MRI in children as a\u00a0diagnostic criterion for neurofibromatosis type 1. Pediatr Radiol 38:305\u2013310. https:\/\/doi.org\/10.1007\/s00247-007-0712-x","journal-title":"Pediatr Radiol"},{"issue":"8","key":"1059_CR23","first-page":"1513","volume":"15","author":"T Itoh","year":"1994","unstructured":"Itoh\u00a0T, Magnaldi\u00a0S, White\u00a0RM et\u00a0al (1994) Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. AJNR Am J Neuroradiol 15(8):1513\u20131519","journal-title":"AJNR Am J Neuroradiol"},{"key":"1059_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-021-05226-1","author":"E Maloney","year":"2021","unstructured":"Maloney\u00a0E, Perez\u00a0FA, Iyer\u00a0RS et al (2021) Non-inferiority of a\u00a0non-gadolinium-enhanced magnetic resonance imaging follow-up protocol for isolated optic pathway gliomas. Pediatr Radiol. https:\/\/doi.org\/10.1007\/s00247-021-05226-1","journal-title":"Pediatr Radiol"},{"key":"1059_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1136\/jmg.36.3.197","volume":"36","author":"JM McGaughran","year":"1999","unstructured":"McGaughran\u00a0JM, Harris\u00a0DI, Donnai\u00a0D et\u00a0al (1999) A clinical study of type 1 neurofibromatosis in north west England. J\u00a0Med Genet 36:197\u2013203. https:\/\/doi.org\/10.1136\/jmg.36.3.197","journal-title":"J Med Genet"},{"key":"1059_CR26","doi-asserted-by":"publisher","first-page":"e20190660","DOI":"10.1542\/peds.2019-0660","volume":"143","author":"DT Miller","year":"2019","unstructured":"Miller\u00a0DT, Freedenberg\u00a0D, Schorry\u00a0E et\u00a0al (2019) Health supervision for children with neurofibromatosis type 1. Pediatrics 143:e20190660. https:\/\/doi.org\/10.1542\/peds.2019-0660","journal-title":"Pediatrics"},{"key":"1059_CR27","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1007\/s00381-020-04775-4","volume":"36","author":"KV Mladenov","year":"2020","unstructured":"Mladenov\u00a0KV, Spiro\u00a0AS, Krajewski\u00a0KL et al (2020) Management of spinal deformities and tibial pseudarthrosis in children with neurofibromatosis type 1 (NF-1). Childs Nerv Syst 36:2409\u20132425. https:\/\/doi.org\/10.1007\/s00381-020-04775-4","journal-title":"Childs Nerv Syst"},{"key":"1059_CR28","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00401-019-02002-2","volume":"139","author":"JS Nix","year":"2020","unstructured":"Nix\u00a0JS, Blakeley\u00a0J, Rodriguez\u00a0FJ (2020) An update on the central nervous system manifestations of neurofibromatosis type 1. Acta Neuropathol 139:625\u2013641. https:\/\/doi.org\/10.1007\/s00401-019-02002-2","journal-title":"Acta Neuropathol"},{"key":"1059_CR29","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.11.7811","author":"NB Patel","year":"2012","unstructured":"Patel\u00a0NB, Stacy\u00a0GS (2012) Musculoskeletal manifestations of neurofibromatosis type 1. AJR Am J Roentgenol. https:\/\/doi.org\/10.2214\/AJR.11.7811","journal-title":"AJR Am J Roentgenol"},{"key":"1059_CR30","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jpeds.2015.07.001","volume":"167","author":"CE Prada","year":"2015","unstructured":"Prada\u00a0CE, Hufnagel\u00a0RB, Hummel\u00a0TR et\u00a0al (2015) The use of magnetic resonance imaging screening for optic pathway gliomas in children with neurofibromatosis type 1. J\u00a0Pediatr 167:851\u2013856.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2015.07.001","journal-title":"J Pediatr"},{"key":"1059_CR31","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jpeds.2015.07.001","volume":"167","author":"CE Prada","year":"2015","unstructured":"Prada\u00a0CE, Hufnagel\u00a0RB, Hummel\u00a0TR et\u00a0al (2015) The use of magnetic resonance imaging screening for optic pathway gliomas in children with neurofibromatosis type 1. J\u00a0Pediatr 167:851\u2013856.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2015.07.001","journal-title":"J Pediatr"},{"key":"1059_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1055\/s-2001-19115","volume":"32","author":"R Raininko","year":"2001","unstructured":"Raininko\u00a0R, Thelin\u00a0L, Eeg-Olofsson\u00a0O (2001) Non-neoplastic brain abnormalities on MRI in children and adolescents with neurofibromatosis type 1. Neuropediatrics 32:225\u2013230. https:\/\/doi.org\/10.1055\/s-2001-19115","journal-title":"Neuropediatrics"},{"key":"1059_CR33","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1007\/s00381-020-04719-y","volume":"36","author":"J Roth","year":"2020","unstructured":"Roth\u00a0J, Constantini\u00a0S, Cinalli\u00a0G (2020) Neurofibromatosis type 1\u2011related hydrocephalus: causes and treatment considerations. Childs Nerv Syst 36:2385\u20132390. https:\/\/doi.org\/10.1007\/s00381-020-04719-y","journal-title":"Childs Nerv Syst"},{"key":"1059_CR34","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.3390\/cancers13081831","volume":"13","author":"C Russo","year":"2021","unstructured":"Russo\u00a0C, Russo\u00a0C, Cascone\u00a0D et al (2021) Non-oncological neuroradiological manifestations in NF1 and their clinical implications. Cancers (Basel) 13:1831. https:\/\/doi.org\/10.3390\/cancers13081831","journal-title":"Cancers (Basel)"},{"key":"1059_CR35","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s00112-005-1156-8","volume":"153","author":"J Seidel","year":"2005","unstructured":"Seidel\u00a0J, Mentzel\u00a0HJ, Eichhorn\u00a0A et al (2005) Neurofibromatose Typ 1 (NF1) im Kindes- und Jugendalter. Merkmalsauspr\u00e4gung, Diagnostik- und Therapieoptionen. Monatsschr Kinderheilkd 153:664\u2013671. https:\/\/doi.org\/10.1007\/s00112-005-1156-8","journal-title":"Monatsschr Kinderheilkd"},{"key":"1059_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2214\/ajr.159.1.1609692","volume":"159","author":"RJ Sevick","year":"1992","unstructured":"Sevick\u00a0RJ, Barkovich\u00a0AJ, Edwards\u00a0MS et\u00a0al (1992) Evolution of white matter lesions in neurofibromatosis type 1: MR findings. AJR Am J Roentgenol 159:171\u2013175. https:\/\/doi.org\/10.2214\/ajr.159.1.1609692","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"1059_CR37","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/01.rct.0000162406.71300.b7","volume":"29","author":"G Tognini","year":"2005","unstructured":"Tognini\u00a0G, Ferrozzi\u00a0F, Garlaschi\u00a0G et\u00a0al (2005) Brain apparent diffusion coefficient evaluation in pediatric patients with neurofibromatosis type 1. J\u00a0Comput Assist Tomogr 29(3):298\u2013304","journal-title":"J Comput Assist Tomogr"},{"key":"1059_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare9070881","author":"G Toro","year":"2021","unstructured":"Toro\u00a0G, Santoro\u00a0C, Ambrosio\u00a0D et\u00a0al (2021) Natural history of scoliosis in children with nf1: an observation study. Healthcare. https:\/\/doi.org\/10.3390\/healthcare9070881","journal-title":"Healthcare"},{"key":"1059_CR39","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1007\/s00117-021-00892-6","volume":"61","author":"M Uhl","year":"2021","unstructured":"Uhl\u00a0M (2021) Musculoskeletal manifestations of neurofibromatosis type 1 (von Recklinghausen\u2019s disease) and tuberous sclerosis (Bourneville\u2019s disease). Radiologe 61:1090\u20131095. https:\/\/doi.org\/10.1007\/s00117-021-00892-6","journal-title":"Radiologe"},{"key":"1059_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1824-7288-40-59","author":"E Vargiami","year":"2014","unstructured":"Vargiami\u00a0E, Sapountzi\u00a0E, Samakovitis\u00a0D et\u00a0al (2014) Moyamoya syndrome and neurofibromatosis type 1. Ital J Pediatr. https:\/\/doi.org\/10.1186\/1824-7288-40-59","journal-title":"Ital J Pediatr"},{"key":"1059_CR41","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.2214\/AJR.09.2724","volume":"194","author":"J Wasa","year":"2010","unstructured":"Wasa\u00a0J, Nishida\u00a0Y, Tsukushi\u00a0S et\u00a0al (2010) MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas. AJR Am J Roentgenol 194:1568\u20131574. https:\/\/doi.org\/10.2214\/AJR.09.2724","journal-title":"AJR Am J Roentgenol"},{"key":"1059_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.01102","author":"A Zahavi","year":"2018","unstructured":"Zahavi\u00a0A, Toledano\u00a0H, Cohen\u00a0R et\u00a0al (2018) Use of optical coherence tomography to detect retinal nerve fiber loss in children with optic pathway glioma. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2018.01102","journal-title":"Front Neurol"},{"key":"1059_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1196-0","author":"G Zhu","year":"2019","unstructured":"Zhu\u00a0G, Zheng\u00a0Y, Liu\u00a0Y et al (2019) Identification and characterization of NF1 and non-NF1 congenital pseudarthrosis of the tibia based on germline NF1 variants: genetic and clinical analysis of 75\u00a0patients. Orphanet J Rare Dis. https:\/\/doi.org\/10.1186\/s13023-019-1196-0","journal-title":"Orphanet J Rare Dis"}],"container-title":["Die Radiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-022-01059-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00117-022-01059-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-022-01059-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T19:11:59Z","timestamp":1669835519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00117-022-01059-7"}},"subtitle":["Von der Diagnose bis zum Follow-up","From diagnosis to follow-up"],"short-title":[],"issued":{"date-parts":[[2022,9,7]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1059"],"URL":"https:\/\/doi.org\/10.1007\/s00117-022-01059-7","relation":{},"ISSN":["2731-7048","2731-7056"],"issn-type":[{"value":"2731-7048","type":"print"},{"value":"2731-7056","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,7]]},"assertion":[{"value":"22 July 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"R.\u00a0Anders, F.W.\u00a0Hirsch und C.\u00a0Roth geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}